Avelumab in Refractory Testicular Germ Cell Cancer.
Conditions: Testicular Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms; Testicular Diseases; Gonadal Disorders; Antineoplastic Agents; Molecular Mechanisms of Pharmacological Action Intervention: Drug: Avelumab Sponsors: National Cancer Institute, Slovakia; Merck Sharp & Dohme Corp. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2018 Category: Research Source Type: clinical trials
Avelumab in Refractory Testicular Germ Cell Cancer.
Conditions: Testicular Neoplasms; Neoplasms, Germ Cell and Embryonal; Neoplasms; Testicular Diseases; Gonadal Disorders; Antineoplastic Agents; Molecular Mechanisms of Pharmacological Action Intervention: Drug: Avelumab Sponsors: National Cancer Institute, Slovakia; Merck KGaA Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 19, 2018 Category: Research Source Type: clinical trials